Berger Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.4M Sell
102,351
-2,051
-2% -$442K 1.3% 15
2026
Q1
$21M Sell
104,402
-10,548
-9% -$2.18M 1.17% 17
2025
Q4
$23.7M Sell
114,950
-545
-0.5% -$109K 1.37% 13
2025
Q3
$20.7M Buy
115,495
+2,476
+2% +$422K 1.24% 18
2025
Q2
$18.2M Buy
113,019
+2,045
+2% +$326K 1.18% 18
2025
Q1
$18.9M Sell
110,974
-43,298
-28% -$7.52M 1.31% 12
2024
Q4
$25.6M Buy
154,272
+1,969
+1% +$336K 1.77% 8
2024
Q3
$26.2M Sell
152,303
-44
-0% -$7.28K 1.89% 8
2024
Q2
$23.5M Buy
152,347
+4,574
+3% +$686K 1.87% 10
2024
Q1
$22.7M Buy
147,773
+25,907
+21% +$3.95M 1.87% 9
2023
Q4
$19.3M Buy
121,866
+7,888
+7% +$1.13M 2% 12
2023
Q3
$16.7M Buy
113,978
+3,560
+3% +$542K 1.92% 13
2023
Q2
$16.9M Buy
110,418
+1,493
+1% +$233K 1.92% 13
2023
Q1
$16.9M Sell
108,925
-22,216
-17% -$3.49M 2.03% 12
2022
Q4
$20.2M Sell
131,141
-3,343
-2% -$493K 2.67% 8
2022
Q3
$17.7M Buy
134,484
+1,929
+1% +$271K 2.61% 8
2022
Q2
$18M Sell
132,555
-4,420
-3% -$609K 2.63% 8
2022
Q1
$20.4M Buy
136,975
+11,965
+10% +$1.77M 2.6% 8
2021
Q4
$20.2M Buy
125,010
+4,557
+4% +$737K 2.68% 6
2021
Q3
$20M Buy
120,453
+1,654
+1% +$283K 3.61% 4
2021
Q2
$20.5M Buy
118,799
+3,256
+3% +$538K 3.71% 4
2021
Q1
$18.5M Buy
115,543
+1,948
+2% +$334K 4.04% 4
2020
Q4
$19.1M Buy
+113,595
New +$18.4M 3.33% 4

Other funds holding FBT

Berger Financial Group's FBT Position: Q2 2026 in Review

Berger Financial Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2% in Q2 2026, selling an estimated $442K and leaving 102,351 shares worth $25.4M. The position accounts for 1.3% of the portfolio, ranked #15.

Berger Financial Group first reported a position in FBT in Q4 2020 and has held it in 23 quarters since. The position peaked at $26.2M in Q3 2024. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Berger Financial Group held 102,351 shares of First Trust NYSE Arca Biotechnology Index Fund worth $25.4M as of Q2 2026.
  • Berger Financial Group sold 2,051 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $442K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 1.3% of Berger Financial Group's portfolio in Q2 2026, its #15 holding.
  • Berger Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 23 quarters since.
  • Berger Financial Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $26.2M in Q3 2024.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Berger Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.